Stay updated on APL-2 Efficacy & Safety in PNH Patients Clinical Trial
Sign up to get notified when there's something new on the APL-2 Efficacy & Safety in PNH Patients Clinical Trial page.

Latest updates to the APL-2 Efficacy & Safety in PNH Patients Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange Detected- Site revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check15 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3, reflecting a minor internal update.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check43 days agoChange DetectedRevision: v3.4.2 was added and the previous notices about funding lapses and operating status were removed. No study data or eligibility information were modified.SummaryDifference0.3%

- Check51 days agoChange DetectedA government funding status notice has been added to the page, indicating that information may not be up to date and directing users to official sources for updates. The page also shows a revision update to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.3%

- Check58 days agoChange DetectedShow glossary added to help interpret terms on the study page. The page now shows the latest QC update status and the new Revision: v3.4.0.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision: v3.3.4 was added and v3.3.3 was removed, reflecting a minor version update; core study details, eligibility criteria, and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to APL-2 Efficacy & Safety in PNH Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APL-2 Efficacy & Safety in PNH Patients Clinical Trial page.